Accéder au contenu
Merck

Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy (2008-03-05)
Pontus Juréen, Jim Werngren, Juan-Carlos Toro, Sven Hoffner
RÉSUMÉ

Thirty-four pyrazinamide-resistant and 37 pyrazinamide-susceptible Mycobacterium tuberculosis complex strains were analyzed for pncA gene mutations. None of the sensitive strains had any mutations, apart from silent mutations, whereas all but one resistant strain showed pncA mutations. By using sequencing as a means of early resistance detection, the inconsistency of phenotypic pyrazinamide assays can be circumvented.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Pyrazinecarboxamide